Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
May 24, 2012 aberman michael s Officer Option Execute 500 24.00
Dec 19, 2007 gilman alfred g Director Disposition (Non Open Market) 500 n/a
Dec 24, 2007 gilman alfred g Director Disposition (Non Open Market) 500 n/a
Oct 1, 2008 goldstein joseph l Director Sell 500 22.32
Feb 4, 2010 roberts william Officer Automatic Sell 514 27.48 - 28.38
May 19, 2010 brown michael s Director Sell 524 27.73
Nov 26, 2013 baker charles a Director Disposition (Non Open Market) 590 n/a
Oct 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 591 n/a
Nov 5, 2007 brown michael s Director Automatic Sell 600 20.67 - 20.87
Jul 27, 2012 goldberg murray a Officer Disposition (Non Open Market) 600 n/a
Jul 14, 2011 vagelos p roy Officer Automatic Sell 658 56.43 - 57.07
Oct 9, 2013 vagelos p roy Officer Disposition (Non Open Market) 679 n/a
Apr 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 700 n/a
Aug 7, 2014 stahl neil Officer Sell 741 340.39 - 341.03
Jul 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 756 n/a
Jan 10, 2014 vagelos p roy Officer Disposition (Non Open Market) 764 n/a
Nov 5, 2007 goldstein joseph l Director Automatic Sell 800 20.64 - 20.87
Nov 5, 2007 goldstein joseph l Director Option Execute 800 7.66
Jul 5, 2013 vagelos p roy Officer Disposition (Non Open Market) 921 n/a
Dec 16, 2014 mccorkle douglas s Officer Sell 943 410.00
Showing 21-40 of 887 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)